Boditech Med Inc. (KOSDAQ:206640)
South Korea · Delayed Price · Currency is KRW 13,120
-20 (-0.15%)
Dec 30, 2025, 3:30 PM KST
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 285.8 billion as of December 30, 2025. Its market cap has decreased by -25.43% in one year.
Market Cap
285.80B
Enterprise Value
281.88B
Revenue
151.75B
Ranking
n/a
PE Ratio
10.49
Stock Price
13,120.00
Market Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 285.80B, an increase of 915.19%. That is a compound annual growth rate of 25.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 286.23B | -22.38% |
| Dec 30, 2024 | 368.76B | -18.12% |
| Dec 28, 2023 | 450.36B | 100.01% |
| Dec 29, 2022 | 225.17B | -41.09% |
| Dec 30, 2021 | 382.21B | -29.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |